FDA UNTITLED_LETTER - Wells Pharmacy, Inc - April 14, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Wells Pharmacy, Inc

Record Details

This UNTITLED LETTER record concerns Wells Pharmacy, Inc, with an inspection on April 14, 2025, issued by the Office of Compounding Quality and Compliance, covering drugs.

Company: Wells Pharmacy, Inc
Inspection Date: April 14, 2025
Product Type: Drugs
Office: Office of Compounding Quality and Compliance
Person: Frances G. Bormel (Director)

Open in Dashboard

ID · 5f6f103c-74d4-428a-8f44-9921cd263e0d

Violation Codes2

21 CFR 211.167(c)21 CFR 211.160(b)

Full citation text and observation details available on the Dashboard.